Type V collagen induces apoptosis of 8701-BC breast cancer cells and enhances m-calpain expression

Breast Cancer Research

Volumn 2, Issue 3, 2000, Pages

  Pucci Minafra, Ida ^a,b   Carella, Cintia ^a   Cirincione, Rosalia ^a   Chimenti, Silvana ^a   Minafra, Salvatore ^a,b   Luparello, Claudio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Centro di OncoBiologia Sperimentale   (Italy)

Author keywords

Apoptosis; Breast cancer; Calpain; Collagen type V; Differential display

Indexed keywords

CALPAIN 2; COLLAGEN TYPE 4; COLLAGEN TYPE 5;

8701 BC CELLLINE; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA FRAGMENTATION; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; M CALPAIN GENE; MOLECULAR MODEL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 85009965881     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr60     Document Type: Article

References (66)

1. Chou JL, Shen ZX, Stolfi RL, Martin DS, Waxman S: Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro. Cancer Res. 1984, 49: 5371-5376.
2. Luparello C, Schillaci R, Pucci-Minafra I, Minafra S: Adhesion, growth and cytoskeletal characteristics of 8701-BC breast carcinoma cells cultured in the presence of type V collagen. Eur J Cancer. 1990, 26: 231-240.
3. Adams JC, Watt FM: Regulation of development and differentiation by the extracellular matrix. Development. 1993, 117: 1183-1198.
4. Hay ED: Extracellular matrix alters epithelial differentiation. Curr Opin Cell. Biol. 1993, 5: 1029-1035.
5. Streuli CH: Extracellular matrix and gene expression in mammary epithelium. Semin Cell Biol. 1993, 4: 203-212.
6. Boudreau N, Werb Z, Bissell MJ: Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci. USA. 1996, 93: 3509-3513.
7. Klemke R, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 1997, 137: 481-492.
8. Luparello C, Sheterline P, Pucci-Minafra I, Minafra S: A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrates. J Cell Sci. 1991, 100: 179-185.
9. Zetter BR, Brightman SE: Cell motility and the extracellular matrix. Curr Opin Cell Biol. 1990, 2: 850-856.
10. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol. 1993, 120: 577-586.
11. Minafra S, Giambelluca C, Andriolo M, Pucci-Minafra I: Cell-cell and cell-collagen interactions influence gelatinase production by human breast carcinoma cell line 8701-BC. Int J Cancer. 1995, 62: 1-7.
12. Roskelley CD, Srebrow A, Bissell MJ: A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol. 1995, 7: 736-747.
13. Danen E, Lafrenie R, Miyamoto S, Yamada K: Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. Cell Adhes Commun. 1998, 6: 217-224.
14. Lelièvre S, Weaver V, Nickerson J, et al: Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc Natl Acad Sci USA. 1998, 95: 14711-14716.
15. Minafra S, Pucci-Minafra I, Tomasino RM, Sciarrino S: Collagen composition in the ductal infiltrating carcinoma of human breast. Cell Biol Int Rep. 1984, 8: 79-85.
16. Pucci-Minafra I, Luparello C, Sciarrino S, Tomasino RM, Minafra S: Quantitative determination of collagen types present in the ductal Infiltrating carcinoma of human mammary gland. Cell Biol Int Rep. 1985, 9: 291-296.
17. Pucci-Minafra I, Luparello C, Andriolo M, Basiricò L, Aquino A, Minafra S: A new form of tumor and foetal collagen with laminin-binding property. Biochemistry. 1993, 32: 7421-7427.
18. Pucci-Minafra I, Andriolo M, Basiricò L, et al: Onco-fetal/laminin-binding collagen from colon carcinoma: detection of new sequences. Biochem Biophys Res Commun. 1995, 207: 852-859. 10.1006/bbrc.1995.1264.
19. Luparello C, Rizzo CP, Schillaci R, Pucci-Minafra I: Fractionation of type V collagen from carcinomatous and dysplasic breast in the presence of alkaline potassium chloride. Analyt Biochem. 1988, 169: 26-32.
20. Minafra S, Morello V, Glorioso F, et al: A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer. 1989, 60: 185-192.
21. Schillaci R, Luparello C, Minafra S: Type I and I-trimer collagens as substrates for breast carcinoma cells in culture. Effect on growth rate, morphological appearence and actin organization. Eur J Cell Biol. 1989, 48: 135-141.
22. Pucci-Minafra I, Luparello C: Type V/type I collagen interactions "in vitro" and growth-inhibitory effect of hybrid substrates on 8701-BC carcinoma cells. J Submicrosc Cytol Pathol. 1991, 23: 67-74.
23. Luparello C: Adhesion to type V collagen and cloning efficiency in agar of 8701-BC breast cancer cells. Eur J Cancer. 1994, 30A: 1400-1401.
24. Pucci-Minafra I, Luparello C, Aquino A, et al: OF/LB collagen promotes chemoinvasion of breast cancer cells and directes epithelial cell migration into granulation tissue of experimental dermal wounds. Int J Oncol. 1995, 6: 1015-1020.
25. Sokolov BP, Prockop DJ: A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes. Nucl Acid Res. 1994, 19: 4009-4015.
26. Johnson GVW, Guttmann RP: Calpains: intact and active?. Bioessays. 1997, 19: 1011-1018.
27. Carafoli E, Molinari M: Calpain: a protease in search of a function?. Biochem Biophys Res Commun. 1998, 247: 193-203. 10.1006/bbrc.1998.8378.
28. Ono Y, Sorimachi H, Suzuki K: Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun. 1998, 245: 289-294. 10.1006/bbrc.1998.8085.
29. Edwards SN, Tolkovsky: Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J Cell Biol. 1994, 124: 537-546.
30. Navarro JN, Olmo N, Lòpez-Conejo MT, Lizarbe MA: Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity. Eur J Clin Invest. 1997, 27: 620-628.
31. Duke RC, Cohen JJ: Morphological and biochemical assays of apoptosis. In Current Protocols in Immunology. Edited by Coogan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. New York: Green Publishing and Wiley-Interscience. 1992, 3.17: 1-3.
32. Barbieri R, Duro G, Izzo V: Enhanced hybridization labelling signals in Southern blotted DNAs fractionated with voltage gradient gel electrophoresis. Electrophoresis. 1998, 19: 643-645.
33. Asaro MR, Izzo V, Barbieri R: Modified apparatus for voltage gradient gel electrophoresis. J Chromatogr. 1999,
34. Squier MKT, Miller ACK, Malkinson AM, Cohen JJ: Calpain activation in apoptosis. J Cell Physiol. 1994, 159: 229-237.
35. Caetano-Anollés G, Bassam BJ, Gresshoff PM: Primer-template interactions during DNA amplification fingerprinting with single arbitrary oligonucleotides. Mol Gen Genet. 1992, 235: 157-165.
36. Doss RP: Differential display without radioactivity - A modified procedure. BioTechniques. 1996, 21: 408-412.
37. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol. 1990, 215: 403-410. 10.1006/jmbi.1990.9999.
38. Gause WC, Adamovicz J: The use of the PCR to quantitate gene expression. PCR Meth Appl. 1994, 3: S123-S135.
39. ++-activated neutral protease. Biochemistry. 1988, 27: 8122-8128.
40. Southby J, O'Keefe LM, Martin TJ, Gillespie MT: Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Br J Cancer. 1995, 72: 702-707.
41. Wang KKW, Posner A, Hajimohammadreza I: Total protein extraction from cultured cells for use in electrophoresis and western blotting. BioTechniques. 1996, 20: 662-668.
42. Sasaki T, Kishi M, Saito M, et al: Inhibitory effect of di- and tripeptidyl aldehydes on calpains and calpastatins. J Enzyme Inhib. 1990, 3: 195-201.
43. Burgeson RE, El Adli FA, Kaitila II, Hollister DW: Fetal membrane collagens: identification of two new collagen α chains. Proc Natl Acad Sci USA. 1976, 73: 2579-2583.
44. 1 (V)-chains (B-chains): an apparent localization in the exocytoskeleton. Collagen Rel Res. 1981, 1: 53-58.
45. Modesti A, Kalebic T, Scarpa S, et al: Type V collagen in human amnion is a 12 nm-fibrillar component of the pericellular interstitium. Eur J Cell Bio. 1984, 35: 246-255.
46. Fichard A, Kleman JP, Ruggiero F: Another look at collagen V and XI molecules. Matrix Biol. 1994, 14: 515-531.
47. von Der Mark K, Ocalan M: Immunofluorescent localization of type V collagen in the chick embryo with monoclonal antibodies. Collagen Rel Res. 1982, 2: 541-555.
48. 2-terminal domain, a putative regulator of corneal fibrillogenesis. J Cell Biol. 1993, 121: 1181-1189.
49. Barsky S, Rao C, Grotendorst G, Liotta L: Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol. 1982, 108: 276-283.
50. Marian B, Danner MW: Skin tumor promotion is associated with increased type V collagen content in the dermis. Carcinogenesis. 1987, 8: 151-154.
51. Grotendorst GR, Seppä HE, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA. 1981, 78: 3669-3672.
52. Leushner JR, Haust MD: Glycoproteins on the surface of smooth muscle cells involved in their interaction with type V collagen. Can J Biochem Cell Biol. 1985, 63: 1176-1182.
53. LeBaron RG, Höök A, Esko JD, Gay S, Höök M: Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion.. J Biol Chem. 1989, 264: 7950-7956.
54. Ruggiero F, Champliaud MF, Garrone R, Aumailley M: Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp Cell Res. 1994, 210: 215-223. 10.1006/excr.1994.1032.
55. Fukuda K, Koshihara Y, Oda H, Ohyama M, Ooyama T: Type V collagen selectively inhibits human endothelial cell proliferation. Biochem Biophys Res Commun. 1988, 151: 1060-1068.
56. Madri JA, Williams SK: Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol. 1983, 97: 153-165.
57. Ziats N, Anderson JM: Human vascular endothelial cell attachment and growth inhibition by type V collagen. J Vasc Surg. 1993, 17: 710-718.
58. Underwood PA, Bean PA, Whitelock JM: Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: role of type V collagen. Atherosclerosis. 1998, 141: 141-152. 10.1016/S0021-9150(98)00164-6.
59. Parekh T, Wang X, Makri-Werzen DM, Greenspan DS, Newman MJ: Type V collagen is an epithelial cell cycle inhibitor that is induced by and mimics the effects of transforming growth factor ß1. Cell Growth Differ. 1998, 9: 423-433.
60. Martin SJ, Green DR, Cotter TG: Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci. 1994, 19: 26-30.
61. Kohli V, Madden JF, Bentley RC, Clavien PA: Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology. 1999, 116: 168-78.
62. Waterhouse NJ, Finucane DM, Green DR, et al: Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 1998, 5: 1051-1061. 10.1038/sj/cdd/4400425.
63. Knepper NB, Savill J, Brown SB: Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem. 1998, 273: 30530-30536.
64. Choi YH, Lee SJ, Nguyen P, et al: Regulation of cyclin D1 by calpain protease. J Biol Chem. 1997, 272: 28479-28484.
65. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B: Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci. 1998, 111: 713-722.
66. Yu W, Simmons-Menchaca M, Gapor A, Sanders BG, Kline K: Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutrition Cancer. 1999, 33: 26-32.